Literature DB >> 13118494

Cardiovascular and respiratory effects of serpasil, a new crystalline alkaloid from Rauwolfia serpentina Benth, in the dog.

J H TRAPOLD, A J PLUMMER, F F YONKMAN.   

Abstract

Entities:  

Keywords:  CARDIOVASCULAR SYSTEM/effect of drugs on; RAUWOLFIA; RESPIRATION/effect of drugs on

Mesh：

Substances：

Year:  1954        PMID： 13118494

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  8 in total

1.  [Effect of reserpine on the cough reflex in cats].

Authors:  K REHDER
Journal:  Klin Wochenschr       Date:  1957-06-15

2.  The effects of reserpine on hypertensive patients over a period of two years.

Authors:  R HODGKINSON
Journal:  Br Heart J       Date:  1956-10

3.  Drug treatment of hypertension.

Authors:  E G MCQUEEN; F H SMIRK
Journal:  Postgrad Med J       Date:  1956-02       Impact factor: 2.401

4.  [The effect of reserpine on skin and muscle circulation in normal and hypertensive subjects].

Authors:  K D BOCK; H MULLER
Journal:  Klin Wochenschr       Date:  1956-03-15

5.  Rauwolfia serpentina (serpasil) in psychiatry.

Authors:  J D GLYNN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1955-08       Impact factor: 10.154

Review 6.  Are biogenic amines involved in the mechanism of action of the tetrahydrocannabinols?

Authors:  R Dagirmanjian; H C Hodge
Journal:  Agents Actions       Date:  1969-11

7.  Effects of reserpine on blood-pressure responses evoked from the hypothalamus.

Authors:  B K ANAND; S DUA; C L MALHOTRA
Journal:  Br J Pharmacol Chemother       Date:  1957-03

8.  Identification and characterisation of serotonin signalling in the potato cyst nematode Globodera pallida reveals new targets for crop protection.

Authors:  Anna Crisford; Fernando Calahorro; Elizabeth Ludlow; Jessica M C Marvin; Jennifer K Hibbard; Catherine J Lilley; James Kearn; Francesca Keefe; Peter Johnson; Rachael Harmer; Peter E Urwin; Vincent O'Connor; Lindy Holden-Dye
Journal:  PLoS Pathog       Date:  2020-10-02       Impact factor: 6.823
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.